Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP748573.RAAhR9spsTAsRadJkgfxynr6l7QnkZTzkGRu_VdU6aJ4Y130_assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP748573.RAAhR9spsTAsRadJkgfxynr6l7QnkZTzkGRu_VdU6aJ4Y130_provenance.
• NP775328.RAko17VhFGyhbSJE509OAXLIXJuArLp2Y5EA91o6TVxaM130_assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP775328.RAko17VhFGyhbSJE509OAXLIXJuArLp2Y5EA91o6TVxaM130_provenance.
• NP350380.RAoABwe7hhhZDKc5YiDXU8PltOhlgWdqS1fyj5rV9oSz8130_assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP350380.RAoABwe7hhhZDKc5YiDXU8PltOhlgWdqS1fyj5rV9oSz8130_provenance.
• NP898097.RAXdV1LmfcDeupABurxkCN-IklaFMvkgF9THh3ABARiIk130_assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898097.RAXdV1LmfcDeupABurxkCN-IklaFMvkgF9THh3ABARiIk130_provenance.
• assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP547234.RA0TBcgMPGqessvH3NwrM4k8vyd3jThimF65pFWBGJo1U130_assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547234.RA0TBcgMPGqessvH3NwrM4k8vyd3jThimF65pFWBGJo1U130_provenance.
• assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP760691.RAGseomoq1R-65UeuC7DWrTymcrsjbJBlJo0uQFY1_4-8130_assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP760691.RAGseomoq1R-65UeuC7DWrTymcrsjbJBlJo0uQFY1_4-8130_provenance.
• NP487012.RAcbdzz0xYmH2DNtBxx6CHMjWh5tO7Jmx-_3Bd4NsMpME130_assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP487012.RAcbdzz0xYmH2DNtBxx6CHMjWh5tO7Jmx-_3Bd4NsMpME130_provenance.
• NP487014.RAcsXyeEgdLABYxFTQqeHXS11srVU5SGYMZlGFR_ttj2E130_assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP487014.RAcsXyeEgdLABYxFTQqeHXS11srVU5SGYMZlGFR_ttj2E130_provenance.
• NP381328.RAn_6nyBWn7cdUB3I2rAnMMntP6VckT97PM8Ragi0yTQU130_assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381328.RAn_6nyBWn7cdUB3I2rAnMMntP6VckT97PM8Ragi0yTQU130_provenance.
• NP381440.RAi1_swhKX7nsu81qgnETwu-CsITJuh9qEar7qhLTc9Po130_assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381440.RAi1_swhKX7nsu81qgnETwu-CsITJuh9qEar7qhLTc9Po130_provenance.
• NP381548.RAuLdmLL4TQmS7-JGTDIBXAWGQj1h2dEwV3HxnKNjieF8130_assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381548.RAuLdmLL4TQmS7-JGTDIBXAWGQj1h2dEwV3HxnKNjieF8130_provenance.
• NP439537.RAhE2da78tHI97UAtUN_MZ4MwIKvnE6-puPVKuhFxH0_k130_assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP439537.RAhE2da78tHI97UAtUN_MZ4MwIKvnE6-puPVKuhFxH0_k130_provenance.
• NP487011.RAgfuoRiLP9SePgqtBqogyzPTaycpk-wWMWX023LHhhZ4130_assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP487011.RAgfuoRiLP9SePgqtBqogyzPTaycpk-wWMWX023LHhhZ4130_provenance.
• NP487013.RAmaplJhgSnfL5X_GaqNYcadDAV3SV-ixA247WqF5ICPM130_assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP487013.RAmaplJhgSnfL5X_GaqNYcadDAV3SV-ixA247WqF5ICPM130_provenance.
• NP487016.RAn6LXiiChQ9o7rw1iXadIJb-P_OIaP9L1KVLSxCiyk30130_assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP487016.RAn6LXiiChQ9o7rw1iXadIJb-P_OIaP9L1KVLSxCiyk30130_provenance.
• NP439300.RA516ZvvUs_xFlmzS2ghf4Rk48W9eH1iYEhjH3JfmW-8U130_assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP439300.RA516ZvvUs_xFlmzS2ghf4Rk48W9eH1iYEhjH3JfmW-8U130_provenance.
• NP439698.RAMaXiESQXkhtqGQXn0v13UEvY1p4ECV0i-6yyZkGuXKg130_assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP439698.RAMaXiESQXkhtqGQXn0v13UEvY1p4ECV0i-6yyZkGuXKg130_provenance.
• NP487010.RAHz5eG7SISIO0LVKs_vCRe0GCNzZzrct1oyWcduGb3_M130_assertion description "[High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP487010.RAHz5eG7SISIO0LVKs_vCRe0GCNzZzrct1oyWcduGb3_M130_provenance.